299 related articles for article (PubMed ID: 28550199)
1. Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.
Schmueck-Henneresse M; Omer B; Shum T; Tashiro H; Mamonkin M; Lapteva N; Sharma S; Rollins L; Dotti G; Reinke P; Volk HD; Rooney CM
J Immunol; 2017 Jul; 199(1):348-362. PubMed ID: 28550199
[TBL] [Abstract][Full Text] [Related]
2. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
Gargett T; Brown MP
Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
[TBL] [Abstract][Full Text] [Related]
3. Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women.
Bere A; Denny L; Hanekom W; Burgers WA; Passmore JA
J Immunol Methods; 2010 Mar; 354(1-2):68-79. PubMed ID: 20149794
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.
Urak R; Walter M; Lim L; Wong CW; Budde LE; Thomas S; Forman SJ; Wang X
J Immunother Cancer; 2017; 5():26. PubMed ID: 28331616
[TBL] [Abstract][Full Text] [Related]
5. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Tsukishiro T; Donnenberg AD; Whiteside TL
Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.
Roth MD
J Exp Med; 1994 Mar; 179(3):857-64. PubMed ID: 8113679
[TBL] [Abstract][Full Text] [Related]
7. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
[TBL] [Abstract][Full Text] [Related]
8. CD81 costimulation skews CAR transduction toward naive T cells.
Schultz LM; Czerwinski DK; Levy R; Levy S
Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35091467
[TBL] [Abstract][Full Text] [Related]
9. Immobilized anti-CD3-induced T cell growth: comparison of the frequency of responding cells within various T cell subsets.
Geppert TD; Lipsky PE
Cell Immunol; 1991 Mar; 133(1):206-18. PubMed ID: 1703926
[TBL] [Abstract][Full Text] [Related]
10. Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
Kaartinen T; Luostarinen A; Maliniemi P; Keto J; Arvas M; Belt H; Koponen J; Mäkinen PI; Loskog A; Mustjoki S; Porkka K; Ylä-Herttuala S; Korhonen M
Cytotherapy; 2017 Jun; 19(6):689-702. PubMed ID: 28411126
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale.
Wang X; Naranjo A; Brown CE; Bautista C; Wong CW; Chang WC; Aguilar B; Ostberg JR; Riddell SR; Forman SJ; Jensen MC
J Immunother; 2012; 35(9):689-701. PubMed ID: 23090078
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-15 on anti-CD3/anti-CD28 induced apoptosis of umbilical cord blood CD4+ T cells.
Lin SJ; Yu JC; Cheng PJ; Hsiao SS; Kuo ML
Eur J Haematol; 2003 Dec; 71(6):425-32. PubMed ID: 14703692
[TBL] [Abstract][Full Text] [Related]
14. Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
Vasir B; Wu Z; Crawford K; Rosenblatt J; Zarwan C; Bissonnette A; Kufe D; Avigan D
J Immunol; 2008 Jul; 181(1):808-21. PubMed ID: 18566447
[TBL] [Abstract][Full Text] [Related]
15. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.
Renner C; Ohnesorge S; Held G; Bauer S; Jung W; Pfitzenmeier JP; Pfreundschuh M
Blood; 1996 Jul; 88(1):236-41. PubMed ID: 8704179
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Flow Cytometry Analysis of Naïve, Memory, and Effector T Cells.
Saxena A; Dagur PK; Biancotto A
Methods Mol Biol; 2019; 2032():129-140. PubMed ID: 31522417
[TBL] [Abstract][Full Text] [Related]
17. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314
[TBL] [Abstract][Full Text] [Related]
18. Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
Zhu F; Shah N; Xu H; Schneider D; Orentas R; Dropulic B; Hari P; Keever-Taylor CA
Cytotherapy; 2018 Mar; 20(3):394-406. PubMed ID: 29287970
[TBL] [Abstract][Full Text] [Related]
19. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.
Torres Chavez A; McKenna MK; Canestrari E; Dann CT; Ramos CA; Lulla P; Leen AM; Vera JF; Watanabe N
J Immunother Cancer; 2019 Nov; 7(1):330. PubMed ID: 31779709
[TBL] [Abstract][Full Text] [Related]
20. Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.
Watanabe K; Terakura S; Martens AC; van Meerten T; Uchiyama S; Imai M; Sakemura R; Goto T; Hanajiri R; Imahashi N; Shimada K; Tomita A; Kiyoi H; Nishida T; Naoe T; Murata M
J Immunol; 2015 Feb; 194(3):911-20. PubMed ID: 25520398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
